View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
In a randomized, double-blind, multicenter trial, researchers are studying the effect of the Responsive Neurostimulator System (RNS) to help patients with uncontrolled epilepsy. Through electrodes implanted in the brain, the device detects seizure activity and delivers stimulation via a low-level electric current to stop it.
The device is placed within the skull and connected by leads to two electrodes implanted in the brain where the main seizure activity occurs. The device continuously monitors the brain's electrical activity. When the device senses electrical activity that signals the start of a seizure, it sends electrical stimulation through the leads to the seizure focus to suppress the seizure. It delivers stimulation to the brain only after sensing seizure activity.
An earlier study of the RNS in 65 adults with uncontrolled epilepsy indicated that the device is safe. The current trial aims to determine if the device is effective in adults with partial-onset seizures refractory to treatment with two or more antiepileptic drugs.
Usually treated with antiepileptic drugs, epilepsy is poorly controlled in 30% to 40% of more than 2 million people in the United States with the condition.
For more information on the device, visit the manufacturer's Web site at http://www.neuropace.com/.
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top